▶ 調査レポート

世界の糖尿病性網膜症治療薬市場：市場規模・現状・予測
• 英文タイトル：Global Diabetic Retinopathy Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の糖尿病性網膜症治療薬市場：市場規模・現状・予測 / Global Diabetic Retinopathy Drugs Market Size, Status and Forecast 2019-2025 / QYR9N7094資料のイメージです。• レポートコード：QYR9N7094
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、糖尿病性網膜症治療薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、オプティナ、イルヴィアン、ベタメタゾン、オズルデックス、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・糖尿病性網膜症治療薬の世界市場規模
・主要企業別市場シェア
・糖尿病性網膜症治療薬の世界市場規模：種類別（ルセンティス、オプティナ、イルヴィアン、ベタメタゾン、オズルデックス、その他）
・糖尿病性網膜症治療薬の世界市場規模：用途別（50〜60歳、60〜70歳、その他）
・糖尿病性網膜症治療薬のアメリカ市場規模（種類別、用途別）
・糖尿病性網膜症治療薬のヨーロッパ市場規模（種類別、用途別）
・糖尿病性網膜症治療薬の中国市場規模（種類別、用途別）
・糖尿病性網膜症治療薬の日本市場規模（種類別、用途別）
・糖尿病性網膜症治療薬の東南アジア市場規模（種類別、用途別）
・糖尿病性網膜症治療薬のインド市場規模（種類別、用途別）
・糖尿病性網膜症治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・糖尿病性網膜症治療薬の世界市場予測（2019年-2025年）
・糖尿病性網膜症治療薬の地域別市場予測（2019年-2025年）
...

Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising markets in the upcoming period.
In 2018, the global Diabetic Retinopathy Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetic Retinopathy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Retinopathy Drugs development in United States, Europe and China.

The key players covered in this study
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
…

Market segment by Type, the product can be split into
Lucentis
Optina
Iluvien
Betamethazone
Ozurdex
Other

Market segment by Application, split into
50-60 Years Old
60-70 Years Old
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetic Retinopathy Drugs status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Retinopathy Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Retinopathy Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Retinopathy Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Lucentis
1.4.3 Optina
1.4.4 Iluvien
1.4.5 Betamethazone
1.4.6 Ozurdex
1.4.7 Other
1.5 Market by Application
1.5.1 Global Diabetic Retinopathy Drugs Market Share by Application (2014-2025)
1.5.2 50-60 Years Old
1.5.3 60-70 Years Old
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diabetic Retinopathy Drugs Market Size
2.2 Diabetic Retinopathy Drugs Growth Trends by Regions
2.2.1 Diabetic Retinopathy Drugs Market Size by Regions (2014-2025)
2.2.2 Diabetic Retinopathy Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Diabetic Retinopathy Drugs Market Size by Manufacturers
3.1.1 Global Diabetic Retinopathy Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Retinopathy Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Retinopathy Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Retinopathy Drugs Key Players Head office and Area Served
3.3 Key Players Diabetic Retinopathy Drugs Product/Solution/Service
3.4 Date of Enter into Diabetic Retinopathy Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diabetic Retinopathy Drugs Market Size by Type (2014-2019)
4.2 Global Diabetic Retinopathy Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Diabetic Retinopathy Drugs Market Size (2014-2019)
5.2 Diabetic Retinopathy Drugs Key Players in United States
5.3 United States Diabetic Retinopathy Drugs Market Size by Type
5.4 United States Diabetic Retinopathy Drugs Market Size by Application

6 Europe
6.1 Europe Diabetic Retinopathy Drugs Market Size (2014-2019)
6.2 Diabetic Retinopathy Drugs Key Players in Europe
6.3 Europe Diabetic Retinopathy Drugs Market Size by Type
6.4 Europe Diabetic Retinopathy Drugs Market Size by Application

7 China
7.1 China Diabetic Retinopathy Drugs Market Size (2014-2019)
7.2 Diabetic Retinopathy Drugs Key Players in China
7.3 China Diabetic Retinopathy Drugs Market Size by Type
7.4 China Diabetic Retinopathy Drugs Market Size by Application

8 Japan
8.1 Japan Diabetic Retinopathy Drugs Market Size (2014-2019)
8.2 Diabetic Retinopathy Drugs Key Players in Japan
8.3 Japan Diabetic Retinopathy Drugs Market Size by Type
8.4 Japan Diabetic Retinopathy Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diabetic Retinopathy Drugs Market Size (2014-2019)
9.2 Diabetic Retinopathy Drugs Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Retinopathy Drugs Market Size by Type
9.4 Southeast Asia Diabetic Retinopathy Drugs Market Size by Application

10 India
10.1 India Diabetic Retinopathy Drugs Market Size (2014-2019)
10.2 Diabetic Retinopathy Drugs Key Players in India
10.3 India Diabetic Retinopathy Drugs Market Size by Type
10.4 India Diabetic Retinopathy Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Diabetic Retinopathy Drugs Market Size (2014-2019)
11.2 Diabetic Retinopathy Drugs Key Players in Central & South America
11.3 Central & South America Diabetic Retinopathy Drugs Market Size by Type
11.4 Central & South America Diabetic Retinopathy Drugs Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Retinopathy Drugs Introduction
12.1.4 Novartis Revenue in Diabetic Retinopathy Drugs Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Bayer Healthcare
12.2.1 Bayer Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Retinopathy Drugs Introduction
12.2.4 Bayer Healthcare Revenue in Diabetic Retinopathy Drugs Business (2014-2019)
12.2.5 Bayer Healthcare Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Retinopathy Drugs Introduction
12.3.4 Roche Revenue in Diabetic Retinopathy Drugs Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Neurotech Pharmaceuticals
12.4.1 Neurotech Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Retinopathy Drugs Introduction
12.4.4 Neurotech Pharmaceuticals Revenue in Diabetic Retinopathy Drugs Business (2014-2019)
12.4.5 Neurotech Pharmaceuticals Recent Development
12.5 Regeneron Pharmaceuticals
12.5.1 Regeneron Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Retinopathy Drugs Introduction
12.5.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Drugs Business (2014-2019)
12.5.5 Regeneron Pharmaceuticals Recent Development
12.6 Allergan
12.6.1 Allergan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Retinopathy Drugs Introduction
12.6.4 Allergan Revenue in Diabetic Retinopathy Drugs Business (2014-2019)
12.6.5 Allergan Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Diabetic Retinopathy Drugs Key Market Segments
Table Key Players Diabetic Retinopathy Drugs Covered
Table Global Diabetic Retinopathy Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Diabetic Retinopathy Drugs Market Size Market Share by Type 2014-2025
Figure Lucentis Figures
Table Key Players of Lucentis
Figure Optina Figures
Table Key Players of Optina
Figure Iluvien Figures
Table Key Players of Iluvien
Figure Betamethazone Figures
Table Key Players of Betamethazone
Figure Ozurdex Figures
Table Key Players of Ozurdex
Figure Other Figures
Table Key Players of Other
Table Global Diabetic Retinopathy Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure 50-60 Years Old Case Studies
Figure 60-70 Years Old Case Studies
Figure Other Case Studies
Figure Diabetic Retinopathy Drugs Report Years Considered
Table Global Diabetic Retinopathy Drugs Market Size 2014-2025 (Million US$)
Figure Global Diabetic Retinopathy Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Diabetic Retinopathy Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Diabetic Retinopathy Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Diabetic Retinopathy Drugs Market Share by Regions 2014-2019
Figure Global Diabetic Retinopathy Drugs Market Share by Regions 2014-2019
Figure Global Diabetic Retinopathy Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Diabetic Retinopathy Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Drugs Market Share by Manufacturers (2014-2019)
Figure Global Diabetic Retinopathy Drugs Market Share by Manufacturers in 2018
Table Global Diabetic Retinopathy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Diabetic Retinopathy Drugs Product/Solution/Service
Table Date of Enter into Diabetic Retinopathy Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Retinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Drugs Market Size Share by Type (2014-2019)
Figure Global Diabetic Retinopathy Drugs Market Size Market Share by Type (2014-2019)
Table Global Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Diabetic Retinopathy Drugs Market Size Share by Application (2014-2019)
Figure Global Diabetic Retinopathy Drugs Market Size Market Share by Application (2014-2019)
Figure Global Diabetic Retinopathy Drugs Revenue Market Share by Application in 2018
Figure United States Diabetic Retinopathy Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Diabetic Retinopathy Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Diabetic Retinopathy Drugs Market Share (2018-2019)
Table United States Diabetic Retinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Diabetic Retinopathy Drugs Market Share by Type (2014-2019)
Table United States Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Diabetic Retinopathy Drugs Market Share by Application (2014-2019)
Figure Europe Diabetic Retinopathy Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Diabetic Retinopathy Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Diabetic Retinopathy Drugs Market Share (2018-2019)
Table Europe Diabetic Retinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Diabetic Retinopathy Drugs Market Share by Type (2014-2019)
Table Europe Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Diabetic Retinopathy Drugs Market Share by Application (2014-2019)
Figure China Diabetic Retinopathy Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Diabetic Retinopathy Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Diabetic Retinopathy Drugs Market Share (2018-2019)
Table China Diabetic Retinopathy Drugs Market Size by Type (2014-20189) (Million US$)
Table China Diabetic Retinopathy Drugs Market Share by Type (2014-2019)
Table China Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table China Diabetic Retinopathy Drugs Market Share by Application (2014-2019)
Figure Japan Diabetic Retinopathy Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Diabetic Retinopathy Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Diabetic Retinopathy Drugs Market Share (2018-2019)
Table Japan Diabetic Retinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Diabetic Retinopathy Drugs Market Share by Type (2014-2019)
Table Japan Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Diabetic Retinopathy Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Diabetic Retinopathy Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Diabetic Retinopathy Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Diabetic Retinopathy Drugs Market Share (2018-2019)
Table Southeast Asia Diabetic Retinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Diabetic Retinopathy Drugs Market Share by Type (2014-2019)
Table Southeast Asia Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Diabetic Retinopathy Drugs Market Share by Application (2014-2019)
Figure India Diabetic Retinopathy Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Diabetic Retinopathy Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Diabetic Retinopathy Drugs Market Share (2018-2019)
Table India Diabetic Retinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table India Diabetic Retinopathy Drugs Market Share by Type (2014-2019)
Table India Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table India Diabetic Retinopathy Drugs Market Share by Application (2014-2019)
Figure Central & South America Diabetic Retinopathy Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Diabetic Retinopathy Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Diabetic Retinopathy Drugs Market Share (2018-2019)
Table Central & South America Diabetic Retinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Diabetic Retinopathy Drugs Market Share by Type (2014-2019)
Table Central & South America Diabetic Retinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Diabetic Retinopathy Drugs Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Diabetic Retinopathy Drugs Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Diabetic Retinopathy Drugs Business (2014-2019)
Table Novartis Recent Development
Table Bayer Healthcare Company Details
Table Bayer Healthcare Revenue in Diabetic Retinopathy Drugs Business (2014-2019)(Million US$)
Figure Bayer Healthcare Revenue Growth Rate in Diabetic Retinopathy Drugs Business (2014-2019)
Table Bayer Healthcare Recent Development
Table Roche Company Details
Table Roche Revenue in Diabetic Retinopathy Drugs Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Diabetic Retinopathy Drugs Business (2014-2019)
Table Roche Recent Development
Table Neurotech Pharmaceuticals Company Details
Table Neurotech Pharmaceuticals Revenue in Diabetic Retinopathy Drugs Business (2014-2019)(Million US$)
Figure Neurotech Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Drugs Business (2014-2019)
Table Neurotech Pharmaceuticals Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Drugs Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Drugs Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Allergan Company Details
Table Allergan Revenue in Diabetic Retinopathy Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Diabetic Retinopathy Drugs Business (2014-2019)
Table Allergan Recent Development
Table Global Diabetic Retinopathy Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Diabetic Retinopathy Drugs Market Size Share by Regions (2019-2025)
Figure Global Diabetic Retinopathy Drugs Market Size Share by Regions in 2025
Figure United States Diabetic Retinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Diabetic Retinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Diabetic Retinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Diabetic Retinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Diabetic Retinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Diabetic Retinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Diabetic Retinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Diabetic Retinopathy Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Diabetic Retinopathy Drugs Market Size by Product (2019-2025)
Figure Global Diabetic Retinopathy Drugs Market Size by Product in 2025
Table Global Diabetic Retinopathy Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Diabetic Retinopathy Drugs Market Size by Application (2019-2025)
Figure Global Diabetic Retinopathy Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の増殖性糖尿病性網膜症市場2019
    Global Proliferative Diabetic Retinopathy Sales Market Report 2019
    QYR9N3782 2019年6月13日 106Pages
    本調査レポートでは、増殖性糖尿病性網膜症の世界市場について調査・分析し、増殖性糖尿病性網膜症のメーカー別販売量、市場シェア分析、種類別販売分析（抗VEGF剤、コルチコステロイド）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企...
  • 世界の糖尿病性神経障害薬市場：市場規模・現状・予測
    Global Diabetic Neuropathy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7093 2019年6月14日 93Pages
    当資料は、糖尿病性神経障害薬のグローバル市場について調査・分析したレポートで、種類別（カルシウムチャンネルアルファ-2デルタリガンド、SNRIとTCA、その他）、用途別（病院、ドラッグストア、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...
  • 世界の糖尿病性ケトアシドーシス治療市場：市場規模・現状・予測
    Global Diabetic Ketoacidosis Treatments Market Size, Status and Forecast 2019-2025
    QYR9N7091 2019年6月14日 96Pages
    当資料は、糖尿病性ケトアシドーシス治療のグローバル市場について調査・分析したレポートで、種類別（補液、電解液の交換、インスリン療法）、用途別（病院、外来治療センター、専門クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...
  • 世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測
    Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7092 2019年6月14日 95Pages
    当資料は、糖尿病性黄斑浮腫の治療のグローバル市場について調査・分析したレポートで、種類別（レーザー光凝固療法、薬理学療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）、用途別（病院、眼科診療所、研究機関、受託研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...
  • 世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測
    Global Diabetic Foot Ulcer Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7090 2019年6月14日 94Pages
    当資料は、糖尿病性足部潰瘍治療薬のグローバル市場について調査・分析したレポートで、種類別（事前創傷包帯、代用皮膚、陰圧創傷治療装置、成長因子）、用途別（病院、専門クリニック、介護センター、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...
  • 世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測
    Global Non Cataplexy Narcolepsy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7681 2019年6月14日 93Pages
    当資料は、非カタプレキシーナルコレプシー薬のグローバル市場について調査・分析したレポートで、種類別（抗酸化薬、覚せい剤、その他）、用途別（子供（18歳未満）、成人（18〜50歳）、高齢者（50歳以上）、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...
  • 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測
    Global Myelodysplastic Syndrome (MDS) Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7611 2019年6月14日 96Pages
    当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の凍結乾燥注射薬市場：市場規模・現状・予測
    Global Lyophilized Injectable Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7487 2019年6月14日 96Pages
    当資料は、凍結乾燥注射薬のグローバル市場について調査・分析したレポートで、種類別（使い捨てバイアル、ポイントオブケア再構成、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の鼻出血薬市場：市場規模・現状・予測
    Global Epistaxis Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7169 2019年6月14日 99Pages
    当資料は、鼻出血薬のグローバル市場について調査・分析したレポートで、種類別（血管収縮薬、麻酔薬、抗生物質軟膏、焼灼剤、その他）、用途別（病院、診療所、小売薬局、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界のテネクテプラーゼ薬市場：市場規模・現状・予測
    Global Tenecteplase Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8112 2019年6月14日 93Pages
    当資料は、テネクテプラーゼ薬のグローバル市場について調査・分析したレポートで、種類別（静脈内投与量、カテーテル内点滴注入量）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界の増殖性糖尿病性網膜症市場2019世界の増殖性糖尿病性網膜症市場2019 The global Proliferative Diabetic Retinopathy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Proliferative Diabetic Retinopathy market status and forecast, categorizes the global Proliferat…
  • 世界の糖尿病性神経障害薬市場：市場規模・現状・予測世界の糖尿病性神経障害薬市場：市場規模・現状・予測 Diabetic neuropathies are nerve damaging disorders associated with diabetes mellitus. These conditions are thought to result from a diabetic microvascular injury involving small blood vessels that supply nerves (vasa nervorum) in addition to macrovascular conditions that can accumulate in diabetic n…
  • 世界の糖尿病性ケトアシドーシス治療市場：市場規模・現状・予測世界の糖尿病性ケトアシドーシス治療市場：市場規模・現状・予測 Diabetic ketoacidosis is diagnosed by blood tests that show high levels of glucose, ketones and acid.In 2018, the global Diabetic Ketoacidosis Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report foc…
  • 世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測 Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving g…
  • 世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測 Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing br…